Results 171 to 180 of about 92,598 (348)
Alimentary Pharmacology &Therapeutics, EarlyView.In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas +18 more
wiley +1 more source
The Relationship of Plasma Zinc Concentration and Hepatic Encephalopathy in Patients with Cirrhosis
مجله دانشکده پزشکی اصفهان, 2014 Background: Zinc deficiency is prevalent in Iran. Regarding the effect of zinc element on pathogenesis of cirrhosis and hepatic encephalopathy, the present study has been designed to assess the zinc deficiency in patients with cirrhosis, with and without
Rahmatollah Rafiei +4 more
doaj
Multimodality magnetic resonance imaging in hepatic encephalopathy: An update
, 2014 Xiaodong Zhang
openalex +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.This study shows that both the total SPSS area and the cumulative SPSS diameter decrease significantly and persistently after TIPS placement, whereas the total shunt diameter increases slightly and the total shunt area remains stable. The relative change in SPSS area serves as an independent predictor of mortality. ABSTRACT We evaluated the dynamics of
Marlene Hintersteininger +14 more
wiley +1 more source
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States [PDF]
, 2021 Michael L. Volk +6 more
openalex +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang +15 more
wiley +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Extracellular matrix (ECM) remodelling biomarkers reflect portal hypertension and disease severity in advanced chronic liver disease (ACLD). However, their predictive value for disease progression is largely restricted to compensated ACLD (cACLD). ABSTRACT Background Extracellular matrix (ECM) remodelling in advanced chronic liver disease (ACLD) is ...
Benedikt Simbrunner +17 more
wiley +1 more source
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
Hepatic Medicine: Evidence and Research, 2019 Cyriac Abby Philips, Sasidharan Rajesh, Philip Augustine, Guruprasad Padsalgi, Rizwan Ahamed The Liver Unit, Cochin Gastroenterology Group, Ernakulam Medical Centre, Cochin, Kerala, India Abstract: Portosystemic shunt (PS) syndrome encompasses a spectrum
Philips CA +4 more
doaj